These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15469598)

  • 21. Alternatives to blood product transfusion in the critically ill: erythropoietin.
    Stubbs JR
    Crit Care Med; 2006 May; 34(5 Suppl):S160-9. PubMed ID: 16617261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management of iron-related anemias in critical illness.
    Pieracci FM; Barie PS
    Crit Care Med; 2006 Jul; 34(7):1898-905. PubMed ID: 16691135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anemia in critical illness.
    Eckardt KU
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):84-9. PubMed ID: 11253745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Iron supplementation during erythropoietin therapy in patients on hemodialysis].
    Svára F; Sulková S; Kvasnićka J; Polakovic V
    Vnitr Lek; 1996 Dec; 42(12):849-52. PubMed ID: 9072885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anemia and erythropoietin in critically ill patients].
    Baginski S; Körner R; Frei U; Eckardt KU
    Zentralbl Chir; 2003 Jun; 128(6):487-92. PubMed ID: 12865954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of iron status monitoring during erythropoietin treatment in uremic predialysis patients.
    Rutkowski B; Debska-Slizień A; Biedunkiewicz B; Bułło B
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():17-21. PubMed ID: 8192528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin and intravenous iron in PBM.
    Ralley FE
    Transfus Apher Sci; 2014 Feb; 50(1):16-9. PubMed ID: 24411666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron metabolism and iron substitution during erythropoietin therapy.
    Sunder-Plassmann G; Hörl WH
    Clin Investig; 1994; 72(6 Suppl):S11-5. PubMed ID: 7950165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of iron in patients on chronic dialysis: mistake and misconceptions.
    Sakiewicz P; Paganini E
    J Nephrol; 1998; 11(1):5-15. PubMed ID: 9561479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
    Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
    Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anemia in miscellaneous diseases--mechanism and treatment--solid tumor].
    Shirakawa S; Minami N; Wada H; Katayama N
    Nihon Rinsho; 1991 Mar; 49(3):704-8. PubMed ID: 2041200
    [No Abstract]   [Full Text] [Related]  

  • 34. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
    Cermák J; Gregora E; Lachmanová J; Brabec V
    Vnitr Lek; 1994 Mar; 40(3):174-8. PubMed ID: 8184571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal anemia of inflammation: the name is self-explanatory.
    Yilmaz MI; Solak Y; Covic A; Goldsmith D; Kanbay M
    Blood Purif; 2011; 32(3):220-5. PubMed ID: 21829013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding and managing anemia in critically ill patients.
    Pearl RG; Pohlman A
    Crit Care Nurse; 2002 Dec; Suppl():1-12; discussion 12-4; quiz 15-6. PubMed ID: 12518573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of inflammation on nutrition, iron status, and erythropoietin responsiveness in ESRD patients.
    Bistrian BR; Carey LA
    Nephrol Nurs J; 2000 Dec; 27(6):616-22. PubMed ID: 16649343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anemia in the critically ill child and adult: a narrative review].
    Demaret P; Loeckx I; Mulder A; Devos P; Lebrun F
    Rev Med Liege; 2014 Jan; 69(1):26-34. PubMed ID: 24640305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of exogenous erythropoietin in critically ill patients.
    MacLaren R; Gasper J; Jung R; Vandivier RW
    J Clin Pharm Ther; 2004 Jun; 29(3):195-208. PubMed ID: 15153081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*.
    Heming N; Lettéron P; Driss F; Millot S; El Benna J; Tourret J; Denamur E; Montravers P; Beaumont C; Lasocki S
    Crit Care Med; 2012 Jul; 40(7):2141-8. PubMed ID: 22564959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.